Mental Health Clinics in Mount Shasta, CA Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Mbs Integrative Psychiatry Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 214 E Lake St, Mount Shasta, CA 96067 Phone: 530-435-5048 Fax: 602-603-5084 |
Jefferson Neurology, Llc Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 822 Pine St, Mount Shasta, CA 96067 Phone: 530-926-1039 |
Diana Muncy Lmft Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1005 Ream Ave, Mount Shasta, CA 96067 Phone: 530-941-2259 |
County Of Siskiyou Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1107 Ream Ave, Mount Shasta, CA 96067 Phone: 530-918-7200 Fax: 530-918-7216 |
Revive Medical Group Ca Pc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 914 Pine St, Mount Shasta, CA 96067 Phone: 203-430-1321 |
Behavioranalystsupervisor Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 809 Mccloud Ave, Mount Shasta, CA 96067 Phone: 530-227-2883 |
Blair Rhodes Mft Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 618 N Mount Shasta Blvd, Mount Shasta, CA 96067 Phone: 530-925-4480 Fax: 530-926-3450 |
News Archive
WISeKey to present Latin American Digital Identification and Trusted cloud computing landscape at MIT conference
Carlos Moreira, Chairman and Founder of WISeKey, is to unveil his vision and plans towards the region in an address to a selected audience of over 500 entrepreneurs and members of the science community in New England during the traditional MIT Latin Conference to be held this week-end in Cambridge, Massachusetts.
Zombie attack guidelines
According to a blog post, the Centre for Disease Control and Prevention has put together tips on how to avoid becoming attacked by zombies. A "Zombie Task Force" acting for the US Government has released official advice on how to survive an undead apocalypse.
RegeneRx joint venture retains Ora to carry out RGN-259/GBT201 clinical trials in U.S.
RegeneRx Biopharmaceuticals, Inc. today announced its U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. to conduct a phase 3 clinical trial for the orphan disorder, neurotrophic keratopathy (NK), and a 2b/3 dose-response, confirmatory trial for dry eye syndrome (DES) in the U.S. Both trials will be testing ReGenTree's preservative-free eye drops, RGN-259/GBT201, this year.
Cedars-Sinai researchers design new procedure to treat stem cell-related corneal blindness
​Researchers in the Cedars-Sinai Regenerative Medicine Institute have designed and tested a novel, minute-long procedure to prepare human amniotic membrane for use as a scaffold for specialized stem cells that may be used to treat some corneal diseases.
› Verified 6 days ago